Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Minority Interest (2020 - 2025)

Intelligent Bio Solutions has reported Minority Interest over the past 5 years, most recently at -$146159.0 for Q2 2024.

  • For Q2 2024, Minority Interest fell 30.52% year-over-year to -$146159.0; the TTM value through Jun 2024 reached -$146159.0, down 30.52%, while the annual FY2024 figure was -$146159.0, 30.52% down from the prior year.
  • Minority Interest for Q2 2024 was -$146159.0 at Intelligent Bio Solutions, down from -$135046.0 in the prior quarter.
  • Over five years, Minority Interest peaked at -$28311.0 in Q2 2020 and troughed at -$146159.0 in Q2 2024.
  • A 5-year average of -$84488.1 and a median of -$82043.5 in 2022 define the central range for Minority Interest.
  • Biggest five-year swings in Minority Interest: crashed 80.94% in 2021 and later fell 28.02% in 2022.
  • Year by year, Minority Interest stood at -$39141.0 in 2020, then tumbled by 53.9% to -$60239.0 in 2021, then crashed by 51.74% to -$91407.0 in 2022, then plummeted by 37.79% to -$125948.0 in 2023, then dropped by 16.05% to -$146159.0 in 2024.
  • Business Quant data shows Minority Interest for INBS at -$146159.0 in Q2 2024, -$135046.0 in Q1 2024, and -$125948.0 in Q4 2023.